Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986

All research papers

2996 approved papers, newest first · showing 901–960.Search instead →

  1. 5 Aug 2026· Physics in medicine and biology· Adaptive radiotherapy· QA & dosimetry· Free full text
    Improved synthetic CT image quality does not guarantee dosimetric agreement in CBCT-based adaptive proton radiotherapy.
    Yeap PL et al.
  2. 5 Aug 2026· Physics in medicine and biology· Adaptive radiotherapy· QA & dosimetry· Free full text
    Decoupling the dosimetric impact of setup errors and anatomical deformations in image-guided radiotherapy using diagnostic-quality FBCT and glmmLasso regularization.
    Zhao L et al.
  3. 5 Aug 2026· Physics in medicine and biology· Adaptive radiotherapy· QA & dosimetry· Free full text
    Reconstructing delivered dose in real time: a beam physics-embedded, language-model-driven approach.
    Wang Y et al.
  4. 5 Aug 2026· BMC medical imaging· Adaptive radiotherapy· Therapeutic· QA & dosimetry
    Online adaptive radiotherapy in pelvic and thoracic cancers - comparing toxicities, clinical outcomes and technical parameters between conventional image-guided radiotherapy and online adaptive radiotherapy - the study protocol for the prospective, registry-based cohort study (PRoART).
    Fischer LA et al.
  5. 5 Aug 2026· AJNR. American journal of neuroradiology· SRS / intracranial· Diagnostic
    Arterial Spin Labeling-Derived Fractional Tumor Burden as a Primary Biomarker for Differentiating Recurrent Tumor from Radiation Necrosis After Stereotactic Radiosurgery.
    Christodoulou R et al.
  6. 5 Aug 2026· Physics in medicine and biology· Patient-specific QA· QA & dosimetry
    A deep learning framework for radiotherapy dose prediction: from MLC motion to patient-specific dose perturbation.
    Chen L et al.
  7. 5 Aug 2026· Physics in medicine and biology· Linac QA· QA & dosimetry· Free full text
    Analytical convolution/superposition modelling of one-dimensional dose profiles with asymmetric energy deposition kernels in homogeneous media.
    Pisaturo O et al.
  8. 5 Aug 2026· European journal of nuclear medicine and molecular imaging· Ga-68 DOTATATE· Diagnostic
    Genotype-location interaction defines the SSTR-PET phenotype in paragangliomas and pheochromocytomas.
    Imperiale A et al.
  9. 5 Aug 2026· European journal of nuclear medicine and molecular imaging· Ga-68 DOTATATE· Theranostic· Therapeutic
    Tumour-absorbed dose and efficacy of peptide receptor radionuclide therapy with [⁹⁰Y]Y-DOTATOC in patients with refractory meningioma: a single-centre experience.
    Schweiger L et al.
  10. 5 Aug 2026· Nuclear medicine communications· Ga-68 PSMA PET· Diagnostic
    68Ga prostate-specific membrane antigen PET/computed tomography in benign and malignant prostatic lesions: a study of maximum standardized uptake value and uptake patterns with clinicopathological correlation.
    Mangale P et al.
  11. 4 Aug 2026· Radiotherapy and oncology· Adaptive radiotherapy· Therapeutic
    Early regression index-guided adaptive dose escalation in locally advanced rectal cancer: results of the prospective THUNDER-2 trial.
    Chiloiro G et al.
  12. 4 Aug 2026· Radiotherapy and oncology· Adaptive radiotherapy· Therapeutic
    Temporal heart dose variations during IMPT for esophageal cancer and the impact of an adaptation protocol.
    Canters R et al.
  13. 4 Aug 2026· Clinical nuclear medicine· Ga-68 PSMA PET· Therapeutic
    Multimodal Management of Advanced Metastatic Prostate Cancer: Excellent Response Following Resection of Brain Metastasis and 177Lu-PSMA Therapy.
    Divband G et al.
  14. 4 Aug 2026· Journal of imaging informatics in medicine· Diagnostic
    Early Follicular Lymphoma Grading via PET-CT Fusion and Bayesian Deep Learning.
    Qian C et al.
  15. 4 Aug 2026· Zeitschrift fur medizinische Physik· QA & dosimetry
    Performance evaluation of the Biograph Trinion EP2 PET/CT system according to NEMA NU2-2018.
    Rausch I et al.
  16. 4 Aug 2026· Research (Washington, D.C.)· Diagnostic
    A New Fluorine-18-Fluoroethyltyrosine Positron-Emission-Tomography/Magnetic-Resonance-Based Tumor Resection Plan Improved the Prognosis of Glioblastoma Patients. A Multicenter Validated Study.
    Cheng Y et al.
  17. 4 Aug 2026· Nuclear medicine communications· Theranostic
    Evolutionary landscape and collaborative networks of global theranostic research in nuclear medicine: a visual bibliometric analysis.
    Jia YN et al.
  18. 4 Aug 2026· Nuclear medicine communications· Ga-68 PSMA PET· Diagnostic
    Association of prostate-specific antigen kinetics with gallium-68 prostate-specific membrane antigen PET/computed tomography positivity in biochemical recurrence after radical prostatectomy.
    Nuthalapati M et al.
  19. 4 Aug 2026· Nuclear medicine communications· Lu-177 DOTATATE· Therapeutic
    Efficacy of intra-arterial [ 177 Lu]Lu-DOTATATE vs. continuation intravenous [ 177 Lu]Lu-DOTATATE peptide receptor radionuclide therapy in nonresponding locally advanced inoperable or liver-dominant metastatic gastroenteropancreatic neuroendocrine tumors.
    Bagasariya R et al.
  20. 4 Aug 2026· Journal of nuclear medicine technology· Radiation safety
    Preparing for Practice, Part 2: A Simulation-Based Curriculum Framework for Radiopharmaceutical Therapy Education-A Program Improvement Initiative.
    Bolin JD.
  21. 4 Aug 2026· EJNMMI radiopharmacy and chemistry· Radiopharmacy
    Stable core-encapsulation of indium-111 in crosslinked polyionic complex micelles and assessment of its biodistribution.
    Mizuno HL et al.
  22. 4 Aug 2026· Biomedical physics & engineering express· Gold-anchor fiducial markers· QA & dosimetry
    Quantifying daily residual motion of bilateral diaphragmatic domes using an iterative detection algorithm for breath-hold radiation therapy.
    Wei J et al.
  23. 4 Aug 2026· Journal of neuro-oncology· SRS / intracranial· Therapeutic
    Brain metastases in triple-negative breast cancer: a systematic review of current trends, treatment strategies, and outcomes.
    Begagić E et al.
  24. 4 Aug 2026· Journal of neuro-oncology· SRS / intracranial· Therapeutic
    The risk of sinus vein thrombosis in patients treated with intraoperative radiotherapy for sinus adjacent tumours.
    Bakos J et al.
  25. 4 Aug 2026· Physical and engineering sciences in medicine· Adaptive radiotherapy· QA & dosimetry
    Pancreas SBRT requires online adaptive treatment to adequately manage motion.
    Young T et al.
  26. 3 Aug 2026· Clinical nuclear medicine· Lu-177 DOTATATE· Therapeutic
    Combination Treatment Strategies With Peptide Receptor Radionuclide Therapy: The Current Status and Potential Future Applications in Theranostics of Neuroendocrine Tumors.
    Parghane RV et al.
  27. 3 Aug 2026· Healthcare (Basel, Switzerland)· Personal / occupational dosimetry· Radiation safety· Free full text
    Radiation Safety Knowledge, Perceptions, and Self-Reported Practices Among Healthcare Workers in Radiology and Nuclear Medicine: A Cross-Sectional Survey.
    Pepele EK et al.
  28. 3 Aug 2026· Clinical and translational radiation oncology· Adaptive radiotherapy· Therapeutic· QA & dosimetry· Free full text
    Workflow and dosimetric results for direct-to-unit single-fraction adaptive lung SBRT delivered on the ONE-STOP prospective pilot clinical trial.
    Forghani F et al.
  29. 3 Aug 2026· Clinical neurology and neurosurgery· SRS / intracranial· Therapeutic
    Clinical utility of early MRI follow-up after radiosurgery for solitary meningiomas: A single center, retrospective analysis.
    Bailey D et al.
  30. 3 Aug 2026· Molecular pharmaceutics· Ac-225 alpha therapy· Therapeutic· Free full text
    Macropa-Based 225Ac-Labeled RGD Peptides for Targeted Alpha Therapy.
    Echigo H et al.
  31. 3 Aug 2026· Cancer treatment and research communications· SBRT delivery· Therapeutic
    Radiotherapy strategies for prostate cancer: Techniques, outcomes, and patient care.
    Khalaji A et al.
  32. 3 Aug 2026· Actas urologicas espanolas· SBRT delivery· Therapeutic
    Real-world treatment of oligometastatic hormone-sensitive prostate cancer: impact of androgen receptor pathway inhibitors, metastasis-directed therapy and primary tumor radiotherapy on survival.
    Samper Ots PM et al.
  33. 3 Aug 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Ac-225 alpha therapy· Therapeutic
    Dosimetry Results from the Phase 1b/3 ACTION-1 Trial of [²²⁵Ac]Ac-DOTATATE (RYZ101) in Patients with Somatostatin Receptor-Expressing, Well-Differentiated GEP-NETs.
    Sgouros G et al.
  34. 3 Aug 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Ga-68 PSMA PET· Diagnostic
    Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing ⁶⁸Ga-PSMA PET/CT.
    Jia KY et al.
  35. 3 Aug 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Lu-177 DOTATATE· Therapeutic
    Nephron-Level Dosimetry Reveals Increased Absorbed Dose Heterogeneity of ¹⁶¹Tb- Versus ¹⁷⁷Lu-DOTATATE in Murine Kidneys Despite Similar Pharmacokinetics.
    Andersson M et al.
  36. 3 Aug 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Lu-177 PSMA· Therapeutic
    Thrombotic Microangiopathy in Patients Treated with ¹⁷⁷Lu-PSMA Combination Therapies.
    Chan JC et al.
  37. 3 Aug 2026· Physics in medicine and biology· OSL dosimetry· QA & dosimetry
    Evaluation of skin dose robustness in breast radiotherapy using VMAT planning technique: a phantom-based surface dosimetry study.
    Yoo D et al.
  38. 3 Aug 2026· Thyroid : official journal of the American Thyroid Association· Diagnostic
    Prognostic Stratification of Brain Metastases from Nonanaplastic Follicular Cell-Derived Thyroid Carcinoma: Results of an International Multicenter Retrospective Study.
    Prinzi A et al.
  39. 3 Aug 2026· Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico· SBRT delivery· QA & dosimetry· Therapeutic
    Intermediate rectal dose is associated with late toxicity after prostate SBRT: a dose-volume histogram principal component analysis.
    Zurita AJW et al.
  40. 2 Aug 2026· The Prostate· Ga-68 PSMA PET· Diagnostic
    Management of De Novo miN1 Prostate Cancer in the PSMA-PET Era.
    McMaster T et al.
  41. 2 Aug 2026· Scientific reports· Diagnostic
    Detection of lung cancer using Kronecker mobile forward harmonic net.
    Prasad JR et al.
  42. 1 Aug 2026· Molecular pharmaceutics· Cyclotron production· Radiopharmacy· Diagnostic
    Automated Radiosynthesis of High-Molar-Activity 4-Borono-2-[18F]Fluorophenylalanine: Validation in Rodent Tumor Models and Nonhuman Primates.
    Ye W et al.
  43. 1 Aug 2026· Journal of medicinal chemistry· Lu-177 PSMA· Therapeutic
    PSMA and Integrin αvβ3 Dual-Targeted Radioligands for Prostate Cancer Targeted Radionuclide Therapy.
    Qi X et al.
  44. 1 Aug 2026· Journal of labelled compounds & radiopharmaceuticals· Cyclotron production· Radiopharmacy· Diagnostic
    Reliable One-Pot Automated Preparation of [<sup>11</sup>C]SL25.1188 for Use in Clinical Imaging Studies.
    Hashimoto H et al.
  45. 1 Aug 2026· Journal of labelled compounds & radiopharmaceuticals· Cyclotron production· Radiopharmacy· Diagnostic
    A Practical Radiosynthesis of (S)-[<sup>11</sup>C]SMBT-1 for MAO-B PET Imaging.
    Akula HK et al.
  46. 1 Aug 2026· Journal of labelled compounds & radiopharmaceuticals· Cyclotron production· Radiopharmacy· Diagnostic
    Simple and Efficient Automated Radiosynthesis of 1-[<sup>18</sup>F]-IPA Using Solid-Phase Extraction Cartridges Purification.
    Dong W et al.
  47. 1 Aug 2026· Radiation protection dosimetry· OSL dosimetry· Radiation safety
    AI-driven triage classification at the 1 Gy threshold using dietary supplements and portable OSL dosimetry.
    Della Monaca S et al.
  48. 1 Aug 2026· Medical physics· Ac-225 alpha therapy· Therapeutic
    An analytical framework for efficient and precision-controlled Monte Carlo simulation of heterogeneous targeted alpha therapy microdosimetry.
    Zhu J et al.
  49. 1 Aug 2026· Journal of applied clinical medical physics· SBRT delivery· QA & dosimetry· Free full text
    A geometry-based scaling model for stereotactic treatment volume definition in stereotactic centralized ablative radiation therapy.
    Siah N et al.
  50. 1 Aug 2026· Radiation protection dosimetry· Personal / occupational dosimetry· Radiation safety
    Mailed dose record review of occupational dosimetry records among Japanese medical radiation workers: the OREMS Study.
    Kitamura H et al.
  51. 1 Aug 2026· Medical physics· TLD dosimetry· QA & dosimetry· Free full text
    Lighting up FLASH and beyond: TLD response across four orders of magnitude in proton dose rate.
    Guan F et al.
  52. 1 Aug 2026· Journal of applied clinical medical physics· Gold-anchor fiducial markers· QA & dosimetry· Free full text
    Impact of MRI slice thickness and fiducial marker orientation on geometric accuracy in multi-echo GRE imaging for prostate radiotherapy planning.
    Hayashi A et al.
  53. 1 Aug 2026· Journal of applied clinical medical physics· MR-linac / MR-guided· QA & dosimetry· Free full text
    Clinical implementation and performance evaluation of a motorized MR-compatible OCTAVIUS 4D system for SBRT patient-specific QA on a 1.5 T MR-LINAC.
    Chevillard C et al.
  54. 1 Aug 2026· Medical physics· Adaptive radiotherapy· QA & dosimetry
    HyperSight CBCT dose calculation accuracy for adaptive head and neck radiotherapy: Results from a prospective clinical trial.
    Yashayaeva A et al.
  55. 1 Aug 2026· Cancer medicine· SRS / intracranial· Therapeutic
    Up to Four-Year Outcomes of Single-Fraction Stereotactic Radiosurgery for Small Brain Metastases: A Competing-Risk Analysis.
    Gruber I et al.
  56. 1 Aug 2026· Journal of applied clinical medical physics· Linac QA· QA & dosimetry
    Commissioning and clinical positioning assessment of a novel surface-guided radiation therapy (SGRT) system at a C-Arm linear accelerator.
    Looe HK et al.
  57. 1 Aug 2026· Neuro-oncology· SRS / intracranial· Therapeutic
    Intracranial progression-free survival correlates with overall survival and varies by tumor subtype in patients with breast cancer and brain metastases.
    Sammons SL et al.
  58. 1 Aug 2026· Neuro-oncology· Ac-225 alpha therapy· Therapeutic
    Radiopharmaceutical therapy provides superior survival advantage for leptomeningeal metastasis compared to external beam radiotherapy.
    Zhao L et al.
  59. 1 Aug 2026· Medical physics· Adaptive radiotherapy· QA & dosimetry
    Equivariant conditional diffusion model for head and neck CT image synthesis from CBCT.
    Altalib A et al.
  60. 1 Aug 2026· Journal of applied clinical medical physics· MR-linac / MR-guided· QA & dosimetry
    Image-based evaluation of a commercial AI synthetic CT generator for brain and prostate MR-only radiotherapy.
    Aire M et al.